Sutro Biopharma EPS Diluted from Extraordinaries (Quarterly) Analysis

Sutro Biopharma, Inc. (STRO)

18.40 -0.02 (-0.11%) USD | NASDAQ | Feb 23, 16:00

18.16 -0.24 (-1.30%) After-Hours: 19:59

View EPS Diluted from Extraordinaries (Quarterly) for STRO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Extraordinaries (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Extraordinaries (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Extraordinaries (Quarterly) Benchmarks

Start Trial

GT Biopharma, Inc.	--
Rhythm Pharmaceuticals, Inc.	--
Crinetics Pharmaceuticals, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--